Background

The risk of gastrointestinal bleeding (GIB) is higher in patients taking dual antiplatelet therapy, but other risk factors for GIB are less well defined.

Methods

We compared 141 patients with in-hospital GIB to 19,181 patients without in-hospital GIB after percutaneous intervention (PCI). We defined GIB as clinical (coffee grounds emesis, melena, or hematochezia) or endoscopic evidence of an actively bleeding upper or lower site. We then performed multivariable logistic regression to establish predictors of in-hospital GIB.

Methods

We compared 141 patients with in-hospital GIB to 19,181 patients without in-hospital GIB after percutaneous intervention (PCI). We defined GIB as clinical (coffee grounds emesis, melena, or hematochezia) or endoscopic evidence of an actively bleeding upper or lower site. We then performed multivariable logistic regression to establish predictors of in-hospital GIB.

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. Editorial Note
2. Acute type A aortic dissection in a patient with ventricular septal defect
3. Adverse outcomes in patients prescribed a proton pump inhibitor following percutaneous coronary intervention with drug-eluting stents
4. Decreasing trend in in-hospital mortality of patients undergoing percutaneous coronary intervention regardless of race or gender with persistent higher mortality rates in women and minorities in the United States

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree